- Events & ActivityEvents & Activity
- Holding(s) in Company
- Update on Lupuzor Phase III Study
- Change of Adviser
- Update on Lupuzor Pivotal Phase III Study
- Update on Cancer Compound IPP-204106 'Nucant'
- Close of Accelerated Bookbuild
- Proposed Accelerated Bookbuild for Vendor Placing
- Half-year Report
- UPDATE ON LUPUZOR'S PIVOTAL PHASE III STUDY
- Second Price Monitoring Extn
As of last trade
ImmuPharma PLC (IMM:LSE) traded at 62.50, -11.12% below its 52-week high of 70.32, set on Feb 17, 2017.
23.00Feb 26 201670.32Feb 17 2017
|Market cap||74.90m GBP|
|EPS (TTM)||-0.0601 GBP|
Data delayed at least 20 minutes, as of Feb 21 2017 13:22 GMT.